PNC Financial Services Group’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $225K | Buy |
|
|||||
|
2025
Q2 | $183K | Sell |
|
|||||
|
2025
Q1 | $661K | Buy |
|
|||||
|
2024
Q4 | $452K | Sell |
|
|||||
|
2024
Q3 | $488K | Buy |
|
|||||
|
2024
Q2 | $432K | Sell |
|
|||||
|
2024
Q1 | $430K | Buy |
|
|||||
|
2023
Q4 | $425K | Sell |
|
|||||
|
2023
Q3 | $374K | Sell |
|
|||||
|
2023
Q2 | $397K | Buy |
|
|||||
|
2023
Q1 | $333K | Sell |
|
|||||
|
2022
Q4 | $424K | Sell |
|
|||||
|
2022
Q3 | $250K | Sell |
|
|||||
|
2022
Q2 | $815K | Buy |
|
|||||
|
2022
Q1 | $879K | Sell |
|
|||||
|
2021
Q4 | $802K | Sell |
|
|||||
|
2021
Q3 | $703K | Buy |
|
|||||
|
2021
Q2 | $1.44M | Buy |
|
|||||
|
2021
Q1 | $1.2M | Buy |
|
|||||
|
2020
Q4 | $1.69M | Hold |
|
|||||
|
2020
Q3 | $1.48M | Hold |
|
|||||
|
2020
Q2 | $1.71M | Buy |
|
|||||
|
2020
Q1 | $58K | Hold |
|
|||||
|
2019
Q4 | $104K | Buy |
|